Chemotherapy for Osteosarcoma without High-Dose Methotrexate: Another Piece in the Puzzle

Publisher： Karger

E-ISSN： 2296-5262|30|5|226-227

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.30, Iss.5, 2007-04, pp. : 226-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single‐center experience of 237 patients

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 6, 2015-11 ,pp. : 662-668

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hypersensitivity reaction to high‐dose methotrexate and successful rechallenge in a pediatric patient with osteosarcoma

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 61, Iss. 2, 2014-02 ,pp. : 373-375

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combined Treatment with High-Dose Methotrexate, Vincristine and Procarbazine, without Intrathecal Chemotherapy, Followed by Consolidation Radiotherapy for Primary Central Nervous System Lymphoma in Immunocompetent Patients

By  

Oncology, Vol. 60, Iss. 2, 2001-02 ,pp. : 134-140

Karger

Access to resources Recommend Favorite

Addition of Rituximab to High-Dose Methotrexate-Based Chemotherapy Improves Survival of Adults with Burkitt Lymphoma/Leukemia

By  

Acta Haematologica, Vol. 127, Iss. 2, 2011-12 ,pp. : 115-117

Karger

Access to resources Recommend Favorite

High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement

By  

Acta Haematologica, Vol. 137, Iss. 2, 2017-01 ,pp. : 93-99

Karger

Access to resources Recommend Favorite